Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/30/2014CN101855220B 对神经性疼痛有活性的药物 Neuropathic pain activity of drugs
07/30/2014CN101827852B 取代的哌啶子基-二氢噻吩并嘧啶 Substituted piperidino - dihydro thienopyrimidine
07/30/2014CN101820762B 透过抑制极光激酶而用于治疗癌症的吡咯并三嗪衍生物 Pyrrole through inhibition of aurora kinases for the treatment of cancer and triazine derivatives
07/30/2014CN101801965B 作为细胞坏死抑制剂的吲哚化合物 As the indole compound necrosis inhibitor
07/30/2014CN101795704B 经口组合物 Oral composition
07/30/2014CN101766606B 一种含有阿莫西林和双氯西林钠的药物组合物 The pharmaceutical compositions containing diclofenac sodium amoxicillin and amoxicillin
07/30/2014CN101687773B 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用 Substituted 2- [2- (phenyl) ethylamino] alkyl amide derivatives and their use as sodium and / or calcium channel modulators Application
07/30/2014CN101641013B 核受体结合剂 Nuclear receptor binding agent
07/30/2014CN101528677B Hdac抑制剂 Hdac inhibitors
07/30/2014CN101522021B 醋酸钙的液体组合物 The liquid composition of calcium acetate,
07/30/2014CN101511823B 多功能生物活性化合物 Multifunctional bioactive compounds
07/30/2014CN101374817B 作为胆甾醇酯转移蛋白cetp的抑制剂的三取代的胺化合物 Tri-substituted amine compound as cholesteryl ester transfer protein inhibitors cetp
07/29/2014US8793074 Sequence covariance networks, methods and uses therefor
07/29/2014US8791299 Compounds for the inhibition of herpes viruses
07/29/2014US8791272 Pyrazole compounds as CRTH2 antagonists
07/29/2014US8791270 Bendamustine pharmaceutical compositions
07/29/2014US8791268 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
07/29/2014US8791267 Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
07/29/2014US8791266 Thyroid hormone β receptor agonist
07/29/2014US8791265 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
07/29/2014US8791263 Cortistatin A analog and use thereof
07/29/2014US8791259 Process for the preparation of Tenofovir
07/29/2014US8791257 Substituted pyrrolotriazines as protein kinase inhibitors
07/29/2014US8791252 Therapy-enhancing glucan
07/29/2014US8791245 Anionic conjugates of glycosylated bacterial metabolite
07/29/2014US8791163 Melatonin ligands having antidepressant activity as well as sleep inducing properties
07/29/2014US8791162 Cathepsin cysteine protease inhibitors
07/29/2014US8791161 Sulfur derivatives as chemokine receptor modulators
07/29/2014US8791160 Tranexamic acid formulations
07/29/2014US8791159 Compound capable of binding S1P receptor and pharmaceutical use thereof
07/29/2014US8791158 Methods of treating meibomian gland dysfunction
07/29/2014US8791157 5-substituted benzofurans as inhibitors of cytochrome P450 2D6
07/29/2014US8791156 Polyacetylene compound, an extract containing the same and application thereof
07/29/2014US8791155 Chroman derivatives
07/29/2014US8791154 High concentration olopatadine ophthalmic composition
07/29/2014US8791152 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
07/29/2014US8791151 Crystalline form of a 3-phenoxymethylpyrrolidine compound
07/29/2014US8791149 Methods of treating traumatic brain injury using pro-neurogenic compounds
07/29/2014US8791148 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/29/2014US8791147 Calcium receptor modulating agents
07/29/2014US8791146 2-alkoxy-substituted dicyanopyridines and their use
07/29/2014US8791144 Substituted N-phenyl-1-(4-Pyridinyl)-1H-pyrazol-3-amines
07/29/2014US8791142 Oxazole pyridine derivatives useful as S1P1 receptor agonists
07/29/2014US8791141 Organic compounds
07/29/2014US8791140 Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyondazole suitable for the treatment of abnormal cell growth in mammals
07/29/2014US8791138 Compositions and methods for alleviating depression or improving cognition
07/29/2014US8791137 Therapeutic compounds
07/29/2014US8791136 Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same
07/29/2014US8791135 Nonpeptide HIV-1 protease inhibitors
07/29/2014US8791134 Nitroso compounds as nitroxyl donors and methods of use thereof
07/29/2014US8791133 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
07/29/2014US8791132 Compounds and methods for treatment of hypertension
07/29/2014US8791131 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
07/29/2014US8791130 Aminopyrimidine derivatives as LRRK2 modulators
07/29/2014US8791129 Phenylquinazoline derivatives
07/29/2014US8791128 Compositions for treating or delaying the onset of hair loss
07/29/2014US8791127 Mucosal bioadhesive slow release carrier for delivering active principles
07/29/2014US8791125 Dihydropyrazolopyrimidinone derivatives
07/29/2014US8791124 Use of phosphordiesterase inhibitors in the treatment of prostatic diseases
07/29/2014US8791123 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
07/29/2014US8791122 Form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and method for producing the same
07/29/2014US8791121 Oligooxopiperazines and methods of making and using them
07/29/2014US8791120 Fast-dissociating dopamine 2 receptor antagonists
07/29/2014US8791119 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta
07/29/2014US8791118 Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
07/29/2014US8791117 Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
07/29/2014US8791116 Myosin light chain kinase inhibitor compounds, compositions and related methods of use
07/29/2014US8791115 Combination of triazine derivatives and insulin sensitisers
07/29/2014US8791114 Dihydropyrazoles
07/29/2014US8791113 2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
07/29/2014US8791112 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
07/29/2014US8791111 Piperidine and piperazine derivatives
07/29/2014US8791110 Anti-arenaviral compounds
07/29/2014US8791109 Compositions containing micronized tanaproget prepared by wet granulation
07/29/2014US8791108 Inhibitors of human immunodeficiency virus replication
07/29/2014US8791107 N-substituted oxazinopteridines and oxazinopteridinones
07/29/2014US8791106 Fused ring pyridine compound
07/29/2014US8791105 Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration
07/29/2014US8791103 Carboxylic acid amides, the preparation thereof and their use as medicaments
07/29/2014US8791102 Acetanilide sphingosine-1-phosphate receptor antagonists
07/29/2014US8791101 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
07/29/2014US8791100 Aryl benzylamine compounds
07/29/2014US8791099 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
07/29/2014US8791098 Bioactive pre-tubulysins and use thereof
07/29/2014US8791097 Anti-tumor activity of CCI-779 in papillary renal cell cancer
07/29/2014US8791096 Heat sterilization of glucocorticosteroids
07/29/2014US8791095 Steroidal CYP17 inhibitors/antiandrogens
07/29/2014US8791094 Treatment of prostate cancer
07/29/2014US8791093 Pharmaceutical delivery systems for treatment of substance abuse and other addictions
07/29/2014US8791092 Molecular tweezers for the treatment of amyloid-related diseases
07/29/2014US8791091 Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
07/29/2014US8791090 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
07/29/2014US8791089 Supporting activities of daily living
07/29/2014US8791081 MGMT inhibitor combination for the treatment of neoplastic disorders
07/29/2014US8791080 Methods for treating gastrointestinal diseases
07/29/2014US8791079 Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mNCE)
07/29/2014US8791078 Cell protection in dialysis patients by administration of a creatine compound
07/29/2014US8791073 Peptide-modified polyurethane compositions and associated methods
07/29/2014US8791060 Composition and use of phyto-percolate for treatment of disease
07/29/2014US8791049 Plant treatment compositions particularly effective in the control of Heteranthera limosa on rice crops, and methods for their use